189 related articles for article (PubMed ID: 2007360)
1. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
Avunduk C; Suliman M; Gang D; Polakowski N; Eastwood GL
Dig Dis Sci; 1991 Apr; 36(4):431-4. PubMed ID: 2007360
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing the eradication of Helicobacter pylori with triple therapy.
Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
[TBL] [Abstract][Full Text] [Related]
3. Eicosanoid synthesis and Helicobacter pylori associated gastritis: increase in leukotriene C4 generation associated with H. pylori colonization.
Ahmed A; Holton J; Vaira D; Smith SK; Hoult JR
Prostaglandins; 1992 Jul; 44(1):75-86. PubMed ID: 1641505
[TBL] [Abstract][Full Text] [Related]
4. The actions of bismuth in the treatment of Helicobacter pylori infection.
Lambert JR; Midolo P
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():27-33. PubMed ID: 9146788
[TBL] [Abstract][Full Text] [Related]
5. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
6. Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.
Westblom TU; Madan E; Subik MA; Duriex DE; Midkiff BR
Scand J Gastroenterol; 1992; 27(3):249-52. PubMed ID: 1502490
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
[TBL] [Abstract][Full Text] [Related]
8. The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Wagner S; Varrentrapp M; Haruma K; Lange P; Müller MJ; Schorn T; Soudah B; Bär W; Gebel M
Z Gastroenterol; 1991 Nov; 29(11):595-8. PubMed ID: 1771934
[TBL] [Abstract][Full Text] [Related]
9. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
[TBL] [Abstract][Full Text] [Related]
10. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
Wagner S; Gebel M; Haruma K; Bär W; Lange P; Freise J; Gladziwa U; Schmidt FW
Gut; 1992 Feb; 33(2):179-83. PubMed ID: 1347278
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention.
Scheiman JM; Greenson JK; Lee J; Cryer B
Aliment Pharmacol Ther; 2003 Jun; 17(12):1535-43. PubMed ID: 12823157
[TBL] [Abstract][Full Text] [Related]
14. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area.
Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V
Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500
[TBL] [Abstract][Full Text] [Related]
15. Association of gastric metaplasia and duodenitis with Helicobacter pylori infection in children.
Shabib SM; Cutz E; Drumm B; Sherman PM
Am J Clin Pathol; 1994 Aug; 102(2):188-91. PubMed ID: 8042587
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.
Hudson N; Balsitis M; Filipowicz F; Hawkey CJ
Gut; 1993 Jun; 34(6):748-51. PubMed ID: 8314505
[TBL] [Abstract][Full Text] [Related]
17. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Khulusi S; Badve S; Patel P; Lloyd R; Marrero JM; Finlayson C; Mendall MA; Northfield TC
Gastroenterology; 1996 Feb; 110(2):452-8. PubMed ID: 8566592
[TBL] [Abstract][Full Text] [Related]
19. Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin.
Graham DY; Klein PD; Evans DG; Evans DJ; Alpert LC; Opekun A; Jerdack GR; Morgan DR
Am J Gastroenterol; 1991 Sep; 86(9):1158-62. PubMed ID: 1882794
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
López-Brea M; Alarcón T
Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
